Cargando…

Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab

BACKGROUND: Dynamic susceptibility contrast (DSC)-MRI is a well-established perfusion MR imaging technique for estimating relative cerebral blood volume (CBV) in primary brain tumors; however, tumors localized to regions with naturally elevated perfusion, including cortical tissue and common vascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leu, Kevin, Enzmann, Dieter R, Woodworth, Davis C, Harris, Robert J, Tran, Anh N, Lai, Albert, Nghiemphu, Phioanh L, Pope, Whitney B, Cloughesy, Timothy F, Ellingson, Benjamin M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331836/ https://www.ncbi.nlm.nih.gov/pubmed/25608485 http://dx.doi.org/10.1186/s40644-014-0031-z

Ejemplares similares

Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
por: Wagle, Naveed, et al.
Publicado: (2010)

Diffusion MRI Characteristics After Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
por: Chang, Warren, et al.
Publicado: (2015)

Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping
por: Banerjee, Pia, et al.
Publicado: (2015)

The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
por: Cho, Nicholas S., et al.
Publicado: (2023)

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease
por: Goldman, Jodi, et al.
Publicado: (2022)

Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma
por: Patel, Kunal S., et al.
Publicado: (2020)

BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
por: Ellingson, Benjamin, et al.
Publicado: (2021)

Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation
por: Shidoh, Satoka, et al.
Publicado: (2022)

Improving B(0) Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation
por: Yao, Jingwen, et al.
Publicado: (2018)

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
por: Ellingson, Benjamin M., et al.
Publicado: (2017)

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
por: Liu, Liang Yen, et al.
Publicado: (2019)

Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI)
por: Wang, Chencai, et al.
Publicado: (2021)

Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
por: Yao, Jingwen, et al.
Publicado: (2020)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
por: Tatekawa, Hiroyuki, et al.
Publicado: (2021)

Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks
por: Wang, Chencai, et al.
Publicado: (2022)

Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry
por: Chakhoyan, Ararat, et al.
Publicado: (2019)

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)

Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study
por: Yao, Jingwen, et al.
Publicado: (2022)

Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression
por: Roques, Margaux, et al.
Publicado: (2022)

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI
por: Hagiwara, Akifumi, et al.
Publicado: (2022)

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas
por: Nghiemphu, Phioanh Leia, et al.
Publicado: (2012)

Daily functioning in glioma survivors: associations with cognitive function, psychological factors and quality of life
por: Van Dyk, Kathleen, et al.
Publicado: (2022)

Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma
por: Hathout, Leith, et al.
Publicado: (2016)

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone
por: Kappadakunnel, Melanie, et al.
Publicado: (2009)

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
por: Cloughesy, Timothy F, et al.
Publicado: (2020)

Preoperative embolization of hypervascular spinal tumors: Two case reports
por: Binh, Nguyen Thai, et al.
Publicado: (2022)

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022)

A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients
por: Liu, Vicki, et al.
Publicado: (2023)

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital “Flipbooks” to Control Systems Theory
por: Ellingson, Benjamin M., et al.
Publicado: (2022)

Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2016)

Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients
por: Smedley, Nova F., et al.
Publicado: (2018)

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
por: de Groot, John F., et al.
Publicado: (2010)

“Aerobic glycolytic imaging” of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
por: Hagiwara, Akifumi, et al.
Publicado: (2021)

Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015)

Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab
por: Patel, Kunal S, et al.
Publicado: (2020)

The Volume-Regulated Anion Channel in Glioblastoma
por: Caramia, Martino, et al.
Publicado: (2019)

Atypical Small Hemangiomas of the Liver: Hypervascular Hemangiomas
por: Nouira, Kais, et al.
Publicado: (2007)

HYPERVASCULAR LIVER LESIONS IN RADIOLOGICALLY NORMAL LIVER
por: AMICO, Enio Campos, et al.
Publicado: (2017)

Arteriovenous malformation in pancreas mimicking hypervascular tumor
por: Ishigami, Keisuke, et al.
Publicado: (2020)

Transarterial Embolization of a Parasellar Hypervascular Tumor
por: Kiyosue, Hiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l8ui3ka3pgpfnptb0264da1m7s